{"cluster": 42, "subcluster": 9, "abstract_summ": "Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an emerging human coronavirus responsible for coronavirus disease 2019 (COVID-19), a predominantly respiratory disease that has become a global pandemic.Also we have summarized the latest research progress on the usage of stem cell therapy, human convalescent serum, interferon's, in the treatment of COVID-19.The ongoing episode of coronavirus disease 19 (COVID-19) has imposed a serious threat to global health and the world economy.The first onset of human coronavirus, SARS (SARS-CoV) appeared in 2003 which spanned five continents having lethal effects on human population accompanied by The Middle East Respiratory Syndrome Coronavirus in 2012 with a death rate of 35%.SARS-CoV-2 is the seventh human coronavirus to be described.CoVs are a single positive-sense RNA virus; mutation rates are higher than DNA viruses and indicate a more effective survival adaption mechanism.", "title_summ": "Epitope-Based Peptide Vaccine Against Severe Acute Respiratory Syndrome-Coronavirus-2 Nucleocapsid Protein: An in silico ApproachA systematic review of antibody mediated immunity to coronaviruses: antibody kinetics, correlates of protection, and association of antibody responses with severity of diseaseThe current understanding and potential therapeutic options to combat COVID-19Origin, Potential Therapeutic Targets and Treatment for Coronavirus Disease (COVID-19)Protective immunity after COVID-19 has been questioned: What can we do without SARS-CoV-2-IgG detection?Protective Adaptive Immunity Against Severe Acute Respiratory Syndrome Coronaviruses 2 (SARS-CoV-2) and Implications for VaccinesSpiking Pandemic Potential: Structural and Immunological aspects of SARS-CoV-2Long-term and herd immunity against SARS-CoV-2: implications from current and past knowledgeForecasting the timeframe of coronavirus and human cells interaction with reverse engineeringVaccination strategies to combat novel corona virus SARS-CoV-2Coronavirus as silent killer: recent advancement to pathogenesis, therapeutic strategy and future perspectivesCovid-19 Pandemic and Current Medical InterventionsThe dynamics of humoral immune responses following SARS-CoV-2 infection and the potential for reinfection.", "title_abstract_phrases": "Protective Adaptive Immunity Against Severe Acute Respiratory Syndrome Coronaviruses 2 (SARS-CoV-2) and Implications for VaccinesSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an emerging human coronavirus responsible for coronavirus disease 2019 (COVID-19), a predominantly respiratory disease that has become a global pandemic.Vaccination strategies to combat novel corona virus SARS-CoV-2The 2019-novel coronavirus disease (COVID-19) is caused by SARS-CoV-2 is transmitted from human to human has recently reported in China.Epitope-Based Peptide Vaccine Against Severe Acute Respiratory Syndrome-Coronavirus-2 Nucleocapsid Protein: An in silico ApproachWith an increasing fatality rate, severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) has emerged as a promising threat to human health worldwide.The first onset of human coronavirus, SARS (SARS-CoV) appeared in 2003 which spanned five continents having lethal effects on human population accompanied by The Middle East Respiratory Syndrome Coronavirus in 2012 with a death rate of 35%.Also we have summarized the latest research progress on the usage of stem cell therapy, human convalescent serum, interferon's, in the treatment of COVID-19.Origin, Potential Therapeutic Targets and Treatment for Coronavirus Disease (COVID-19)The ongoing episode of coronavirus disease 19 (COVID-19) has imposed a serious threat to global health and the world economy."}